Sorafenib - induced thyroiditis in patient with a relapse of acute myelomonocytic leukemia with FLT3-ITD mutation

Sorafenib has been used in acute myeloid leukemias with FLT3-ITD mutation improving the outcomes. However the high incidence of treatment - emergent adverse event may be associated with treatment using sorafenib with cytotoxic chemotherapy. We have reported a case of severe thyroiditis in patient wi...

Full description

Bibliographic Details
Main Authors: Ya B Balzhanova, E N Parovichnikova, A N Sokolov, V V Ryzhko, M A Samtsova, E O Gribanova
Format: Article
Language:Russian
Published: "Consilium Medicum" Publishing house 2019-08-01
Series:Терапевтический архив
Subjects:
Online Access:https://ter-arkhiv.ru/0040-3660/article/viewFile/33640/pdf
_version_ 1831652225855782912
author Ya B Balzhanova
E N Parovichnikova
A N Sokolov
V V Ryzhko
M A Samtsova
E O Gribanova
author_facet Ya B Balzhanova
E N Parovichnikova
A N Sokolov
V V Ryzhko
M A Samtsova
E O Gribanova
author_sort Ya B Balzhanova
collection DOAJ
description Sorafenib has been used in acute myeloid leukemias with FLT3-ITD mutation improving the outcomes. However the high incidence of treatment - emergent adverse event may be associated with treatment using sorafenib with cytotoxic chemotherapy. We have reported a case of severe thyroiditis in patient with a relapse of acute myelomonocytic leukemia.
first_indexed 2024-12-19T15:42:38Z
format Article
id doaj.art-b9a1b8a086bc4b1b969dc76acafd6130
institution Directory Open Access Journal
issn 0040-3660
2309-5342
language Russian
last_indexed 2024-12-19T15:42:38Z
publishDate 2019-08-01
publisher "Consilium Medicum" Publishing house
record_format Article
series Терапевтический архив
spelling doaj.art-b9a1b8a086bc4b1b969dc76acafd61302022-12-21T20:15:25Zrus"Consilium Medicum" Publishing houseТерапевтический архив0040-36602309-53422019-08-01918939710.26442/00403660.2019.08.00038130369Sorafenib - induced thyroiditis in patient with a relapse of acute myelomonocytic leukemia with FLT3-ITD mutationYa B Balzhanova0E N Parovichnikova1A N Sokolov2V V Ryzhko3M A Samtsova4E O Gribanova5National Research Center for HematologyNational Research Center for HematologyNational Research Center for HematologyNational Research Center for HematologyNational Research Center for HematologyNational Research Center for HematologySorafenib has been used in acute myeloid leukemias with FLT3-ITD mutation improving the outcomes. However the high incidence of treatment - emergent adverse event may be associated with treatment using sorafenib with cytotoxic chemotherapy. We have reported a case of severe thyroiditis in patient with a relapse of acute myelomonocytic leukemia.https://ter-arkhiv.ru/0040-3660/article/viewFile/33640/pdfsorafenibthyroiditisacute myeloid leukemiarelapseflt3-itd mutation
spellingShingle Ya B Balzhanova
E N Parovichnikova
A N Sokolov
V V Ryzhko
M A Samtsova
E O Gribanova
Sorafenib - induced thyroiditis in patient with a relapse of acute myelomonocytic leukemia with FLT3-ITD mutation
Терапевтический архив
sorafenib
thyroiditis
acute myeloid leukemia
relapse
flt3-itd mutation
title Sorafenib - induced thyroiditis in patient with a relapse of acute myelomonocytic leukemia with FLT3-ITD mutation
title_full Sorafenib - induced thyroiditis in patient with a relapse of acute myelomonocytic leukemia with FLT3-ITD mutation
title_fullStr Sorafenib - induced thyroiditis in patient with a relapse of acute myelomonocytic leukemia with FLT3-ITD mutation
title_full_unstemmed Sorafenib - induced thyroiditis in patient with a relapse of acute myelomonocytic leukemia with FLT3-ITD mutation
title_short Sorafenib - induced thyroiditis in patient with a relapse of acute myelomonocytic leukemia with FLT3-ITD mutation
title_sort sorafenib induced thyroiditis in patient with a relapse of acute myelomonocytic leukemia with flt3 itd mutation
topic sorafenib
thyroiditis
acute myeloid leukemia
relapse
flt3-itd mutation
url https://ter-arkhiv.ru/0040-3660/article/viewFile/33640/pdf
work_keys_str_mv AT yabbalzhanova sorafenibinducedthyroiditisinpatientwitharelapseofacutemyelomonocyticleukemiawithflt3itdmutation
AT enparovichnikova sorafenibinducedthyroiditisinpatientwitharelapseofacutemyelomonocyticleukemiawithflt3itdmutation
AT ansokolov sorafenibinducedthyroiditisinpatientwitharelapseofacutemyelomonocyticleukemiawithflt3itdmutation
AT vvryzhko sorafenibinducedthyroiditisinpatientwitharelapseofacutemyelomonocyticleukemiawithflt3itdmutation
AT masamtsova sorafenibinducedthyroiditisinpatientwitharelapseofacutemyelomonocyticleukemiawithflt3itdmutation
AT eogribanova sorafenibinducedthyroiditisinpatientwitharelapseofacutemyelomonocyticleukemiawithflt3itdmutation